Cytodyn Inc (CYDY)

[DonDonDonDon]

Also, as someone else mentioned, what happened to the 28 CSP patients? Why no mention of this?

38% of critical patients who received leronlimab in the trial passed away within 28 days. If 11 of the 28 original Filipino patients passed away, that is the kind of news that CytoDyn keeps secret. Just like the severe patients in the CD12. Severe patients represent 5/6ths of the trial and we know absolutely nothing about their data.

HGEN has already released a preprint for their trial. HGEN's trial finished a month after leronlimab's CD12 trial. But then again, we are still waiting on the leronlimab's M2M trial data that finished last summer.